The apparent poorer response to a treatment program, which has proven effective in treating children with obesity in general [19, 27], may indicate that children carrying damaging MC4R mutations need a more explorative and likely more intensive program when aiming to reduce BMI SDS. This evidence concerns the gene MC4R and obesity due to melanocortin 4 receptor deficiency.